We are monitoring the impact of COVID-19 on APAC Molecular Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date March, 2021
ID: 11359
Share on
Share on

APAC Molecular Diagnostics Market Analysis Report – Segmented By Products and Service, Technology, End-User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Forecast (2021 to 2026)

Pulished: March, 2021
ID: 11359
Pages: 100

APAC Molecular Diagnostics Market Size (2021 to 2026)

The Asia Pacific Molecular Diagnostics Market size is forecasted to be growing at a CAGR of 12.64% between 2021 to 2026.

The market is primarily driven by the factors such as an increase in the prevalence of cancers in APAC, growth in the biomarkers identification market, and rising acceptance of personalized medicine and companion diagnostics. In the APAC region, China has witnessed a spike in the aging population. It is expected to increase the molecular diagnostic market. In recent periods, an increase in chronic conditions such as diabetes, cancer, and heart disease across the APAC region is anticipated to augment the molecular diagnostics market. Government initiatives to make precision medicine approach a standard practice and growing awareness among the people in this region about molecular diagnostics are projected to propel the market growth.

The market growth is restricted by challenging factors such as lack of professionals for the molecular diagnostic procedures and stringent regulatory requirements for new molecular diagnostic techniques to hinder the Asia Pacific oncology molecular diagnostic market growth. The knowledge of molecular diagnostics technologies is essential for carrying out molecular diagnostic tests, which is considered one of the challenging market growth factors. Rapid mutation of microbes and the rising outbreak of epidemics further restricted the market growth.

Impact of COVID-19 on the APAC molecular diagnostic market:

The emergence of COVID-19 has been affecting millions of people and led to devastating mortality worldwide.

The pandemic had negatively impacted the molecular diagnostics market's market growth during the first quarter of 2020. The sudden emergence of the outbreak led to a reduction in testing rates and decreased cancer patient visits to the hospital. It impacted the labs involved in oncology testing due to lab resources' realignment towards proving COVID-19 testing. Reports show a decline in newly diagnosed cancer patients of 8.4% during the pandemic period and a reduction by 31% of patients diagnosed with lung cancer since the outbreak.

This research report on the Asia-Pacific molecular diagnostics market has been segmented and sub-segmented into the following categories.

By Products and Service:

  • Reagents and kits
  • Instruments
  • Software and service

By Technology:

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)3.
  • DNA Sequencing and NGS
  • DNA Microarrays
  • In Situ Hybridization
  • Other Technologies

By End-User:

  • Hospital and Academic Laboratories
  • Reference Laboratories
  • Other End-Users

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, The Asia Pacific molecular diagnostic market recorded a substantial market share in 2019, and it is expected to hold the largest market share during the forecast period. The market size is estimated to reach USD 712.05 million by 2026 and grows at a CAGR of 12.6% during the forecast period. In the APAC region, China, India, Japan, and Australia are significant contributors to the molecular diagnostics market.

In APAC, the Australian market is projected to hold the leading market share during the forecast period and was worth USD 91.26 million in 2020. It is projected to reach USD 175.55 million by 2026. The Australian market growth is attributed to the increase in the incidence of cancer. Moreover, with the accelerating demand for faster cancer diagnosis, the Australian market is estimated to contribute its share to the APAC region.

China accounted for the largest market share of the molecular diagnostic market over the forecast period and is anticipated to continue its stake in the coming years. In the APAC region, a spike in China's aging population is more likely to expand the molecular diagnostic market's market growth. China is involved in launching innovative devices with technologies for multiple therapeutic areas to create market growth.

India has been showing a significant spike in the molecular diagnostic market over the forecast period. Increasing government initiatives in India and rising molecular diagnostic procedures proliferate due to the rising demand to accelerate the market growth.

Japan is more likely to raise its market growth of the molecular diagnostic market during the forecast period. Japan announced its launch of a new product, in-vitro diagnostics. Increasing infectious diseases and the adoption of innovative personalized medicines are projected to influence market growth.

Abbott Laboratories, Agilent Technologies, Becton, Dickinson And Company, Biomérieux SA, Danaher Corporation, Diasorin, Grifols, Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific are some of the companies playing a prominent role in the APAC molecular diagnostics market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Products and Service:
      1. Reagents and kits
      2. Instruments
      3. Software and service
    2. By Technology:
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)3.
      3. DNA Sequencing and NGS
      4. DNA Microarrays
      5. In Situ Hybridization
      6. Other Technologies
    3. By End-User:
      1. Hospital and Academic Laboratories
      2. Reference Laboratories
      3. Other End-Users
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
      7. Rest of APAC
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Abbott Laboratories
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Agilent Technologies
    3. Becton, Dickinson And Company
    4. Biomérieux SA
    5. Danaher Corporation
    6. Diasorin
    7. Grifols
    8. Hologic
    9. Illumina
    10. Qiagen
    11. Roche Diagnostics
    12. Siemens Healthineers
    13. Thermo Fisher Scientific.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Products and Services Market, By Application, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Reagents and kits Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Software and service Market, By Region, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Products and Services Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Polymerase Chain Reaction (PCR) Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT)3 Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific DNA Sequencing and NGS Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific DNA Microarrays Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific In Situ Hybridization Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Other Technologies Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Products and Services Market, By End-User, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Hospital and Academic Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia Pacific Reference Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  15. Asia Pacific Other End-Users Market, By Region, From 2021 to 2026 (USD Billion)
  16. Japan Products and Services Market, By Application, From 2021 to 2026 (USD Billion)
  17. Japan Products and Services Market, By Technology, From 2021 to 2026 (USD Billion)
  18. Japan Products and Services Market, By End-User, From 2021 to 2026 (USD Billion)
  19. China Products and Services Market, By Application, From 2021 to 2026 (USD Billion)
  20. China Products and Services Market, By Technology, From 2021 to 2026 (USD Billion)
  21. China Products and Services Market, By End-User, From 2021 to 2026 (USD Billion)
  22. India Products and Services Market, By Application, From 2021 to 2026 (USD Billion)
  23. India Products and Services Market, By Technology, From 2021 to 2026 (USD Billion)
  24. India Products and Services Market, By End-User, From 2021 to 2026 (USD Billion)
  25. Australia Products and Services Market, By Application, From 2021 to 2026 (USD Billion)
  26. Australia Products and Services Market, By Technology, From 2021 to 2026 (USD Billion)
  27. Australia Products and Services Market, By End-User, From 2021 to 2026 (USD Billion)
  28. South Korea Products and Services Market, By Application, From 2021 to 2026 (USD Billion)
  29. South Korea Products and Services Market, By Technology, From 2021 to 2026 (USD Billion)
  30. South Korea Products and Services Market, By End-User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample